CDNA – caredx, inc. (US:NASDAQ)

News

CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com